123 related articles for article (PubMed ID: 9103732)
1. Cognitive-behavioral stress management decreases dysphoric mood and herpes simplex virus-type 2 antibody titers in symptomatic HIV-seropositive gay men.
Lutgendorf SK; Antoni MH; Ironson G; Klimas N; Kumar M; Starr K; McCabe P; Cleven K; Fletcher MA; Schneiderman N
J Consult Clin Psychol; 1997 Feb; 65(1):31-43. PubMed ID: 9103732
[TBL] [Abstract][Full Text] [Related]
2. Reductions in herpes simplex virus type 2 antibody titers after cognitive behavioral stress management and relationships with neuroendocrine function, relaxation skills, and social support in HIV-positive men.
Cruess S; Antoni M; Cruess D; Fletcher MA; Ironson G; Kumar M; Lutgendorf S; Hayes A; Klimas N; Schneiderman N
Psychosom Med; 2000; 62(6):828-37. PubMed ID: 11139003
[TBL] [Abstract][Full Text] [Related]
3. Changes in cognitive coping skills and social support during cognitive behavioral stress management intervention and distress outcomes in symptomatic human immunodeficiency virus (HIV)-seropositive gay men.
Lutgendorf SK; Antoni MH; Ironson G; Starr K; Costello N; Zuckerman M; Klimas N; Fletcher MA; Schneiderman N
Psychosom Med; 1998; 60(2):204-14. PubMed ID: 9560871
[TBL] [Abstract][Full Text] [Related]
4. Cognitive behavioral stress management effects on mood, social support, and a marker of antiviral immunity are maintained up to 1 year in HIV-infected gay men.
Carrico AW; Antoni MH; Pereira DB; Fletcher MA; Klimas N; Lechner SC; Schneiderman N
Int J Behav Med; 2005; 12(4):218-26. PubMed ID: 16262540
[TBL] [Abstract][Full Text] [Related]
5. Cognitive-behavioral stress management reduces distress and 24-hour urinary free cortisol output among symptomatic HIV-infected gay men.
Antoni MH; Cruess S; Cruess DG; Kumar M; Lutgendorf S; Ironson G; Dettmer E; Williams J; Klimas N; Fletcher MA; Schneiderman N
Ann Behav Med; 2000; 22(1):29-37. PubMed ID: 10892526
[TBL] [Abstract][Full Text] [Related]
6. Psychosocial modulation of antibody to Epstein-Barr viral capsid antigen and human herpesvirus type-6 in HIV-1-infected and at-risk gay men.
Esterling BA; Antoni MH; Schneiderman N; Carver CS; LaPerriere A; Ironson G; Klimas NG; Fletcher MA
Psychosom Med; 1992; 54(3):354-71. PubMed ID: 1320279
[TBL] [Abstract][Full Text] [Related]
7. Cognitive-behavioral stress management intervention effects on anxiety, 24-hr urinary norepinephrine output, and T-cytotoxic/suppressor cells over time among symptomatic HIV-infected gay men.
Antoni MH; Cruess DG; Cruess S; Lutgendorf S; Kumar M; Ironson G; Klimas N; Fletcher MA; Schneiderman N
J Consult Clin Psychol; 2000 Feb; 68(1):31-45. PubMed ID: 10710838
[TBL] [Abstract][Full Text] [Related]
8. Increases in a marker of immune system reconstitution are predated by decreases in 24-h urinary cortisol output and depressed mood during a 10-week stress management intervention in symptomatic HIV-infected men.
Antoni MH; Cruess DG; Klimas N; Carrico AW; Maher K; Cruess S; Lechner SC; Kumar M; Lutgendorf S; Ironson G; Fletcher MA; Schneiderman N
J Psychosom Res; 2005 Jan; 58(1):3-13. PubMed ID: 15771864
[TBL] [Abstract][Full Text] [Related]
9. Cognitive-behavioral stress management intervention buffers distress responses and immunologic changes following notification of HIV-1 seropositivity.
Antoni MH; Baggett L; Ironson G; LaPerriere A; August S; Klimas N; Schneiderman N; Fletcher MA
J Consult Clin Psychol; 1991 Dec; 59(6):906-15. PubMed ID: 1774375
[TBL] [Abstract][Full Text] [Related]
10. Cognitive-behavioral stress management increases free testosterone and decreases psychological distress in HIV-seropositive men.
Cruess DG; Antoni MH; Schneiderman N; Ironson G; McCabe P; Fernandez JB; Cruess SE; Klimas N; Kumar M
Health Psychol; 2000 Jan; 19(1):12-20. PubMed ID: 10711583
[TBL] [Abstract][Full Text] [Related]
11. Reductions in depressed mood and denial coping during cognitive behavioral stress management with HIV-Positive gay men treated with HAART.
Carrico AW; Antoni MH; Duran RE; Ironson G; Penedo F; Fletcher MA; Klimas N; Schneiderman N
Ann Behav Med; 2006 Apr; 31(2):155-64. PubMed ID: 16542130
[TBL] [Abstract][Full Text] [Related]
12. Cognitive-behavioural stress management with HIV-positive homosexual men: mechanisms of sustained reductions in depressive symptoms.
Carrico AW; Antoni MH; Weaver KE; Lechner SC; Schneiderman N
Chronic Illn; 2005 Sep; 1(3):207-15. PubMed ID: 17152183
[TBL] [Abstract][Full Text] [Related]
13. Randomized clinical trial of cognitive behavioral stress management on human immunodeficiency virus viral load in gay men treated with highly active antiretroviral therapy.
Antoni MH; Carrico AW; Durán RE; Spitzer S; Penedo F; Ironson G; Fletcher MA; Klimas N; Schneiderman N
Psychosom Med; 2006; 68(1):143-51. PubMed ID: 16449425
[TBL] [Abstract][Full Text] [Related]
14. Reductions in salivary cortisol are associated with mood improvement during relaxation training among HIV-seropositive men.
Cruess DG; Antoni MH; Kumar M; Schneiderman N
J Behav Med; 2000 Apr; 23(2):107-22. PubMed ID: 10833675
[TBL] [Abstract][Full Text] [Related]
15. Cognitive-behavioral stress management buffers decreases in dehydroepiandrosterone sulfate (DHEA-S) and increases in the cortisol/DHEA-S ratio and reduces mood disturbance and perceived stress among HIV-seropositive men.
Cruess DG; Antoni MH; Kumar M; Ironson G; McCabe P; Fernandez JB; Fletcher M; Schneiderman N
Psychoneuroendocrinology; 1999 Jul; 24(5):537-49. PubMed ID: 10378240
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of antibodies to herpes simplex virus 2 among homosexual men either positive or negative for human immunodeficiency viruses in Slovakia.
Bystrická M; Gasparovicová L; Staneková D; Mokrás M; Soláriková L; Russ G
Acta Virol; 2000; 44(3):163-7. PubMed ID: 11155359
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of herpes simplex virus types 2 and 1 amongst men who have sex with men attending sexual health clinics in England and Wales: implications for HIV prevention and management.
Hill C; McKinney E; Lowndes CM; Munro H; Murphy G; Parry JV; Gill ON;
Euro Surveill; 2009 Nov; 14(47):. PubMed ID: 19941804
[TBL] [Abstract][Full Text] [Related]
18. Herpes simplex virus type 2 in Brazil: seroepidemiologic survey.
Da Rosa-Santos OL; Gonçalves Da Silva A; Pereira AC
Int J Dermatol; 1996 Nov; 35(11):794-6. PubMed ID: 8915732
[TBL] [Abstract][Full Text] [Related]
19. Increased genital shedding of herpes simplex virus type 2 in HIV-seropositive women.
Augenbraun M; Feldman J; Chirgwin K; Zenilman J; Clarke L; DeHovitz J; Landesman S; Minkoff H
Ann Intern Med; 1995 Dec; 123(11):845-7. PubMed ID: 7486467
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir.
Hensel MT; Marshall JD; Dorwart MR; Heeke DS; Rao E; Tummala P; Yu L; Cohen GH; Eisenberg RJ; Sloan DD
J Virol; 2017 May; 91(9):. PubMed ID: 28228587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
